Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate

Product Overview

Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate represents a critical building block in the modern pharmaceutical landscape, specifically designed for the synthesis of advanced antidiabetic agents. As a key intermediate in the production of Sitagliptin, this compound plays an indispensable role in the manufacturing chain of leading therapeutic solutions for diabetes management. Our facility specializes in the large-scale production of this high-value chemical, ensuring consistent quality and reliable supply for global pharmaceutical manufacturers.

The chemical structure features a trifluorophenyl group attached to a butanoate backbone, providing unique reactivity profiles essential for downstream coupling reactions. This specific configuration allows for efficient conversion into active pharmaceutical ingredients (APIs) while maintaining high stereochemical integrity. Our production processes are optimized to maximize yield and minimize impurities, adhering to strict international standards for pharmaceutical intermediates.

Technical Specifications

Quality Assurance And Production

Quality is the cornerstone of our manufacturing philosophy. Every batch of Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate undergoes rigorous analytical testing using high-performance liquid chromatography (HPLC) to verify purity levels exceeding 98.0%. We maintain comprehensive documentation for each production run, including Certificates of Analysis (COA), Method of Analysis (MOA), and Material Safety Data Sheets (MSDS). Our quality control laboratories are equipped with state-of-the-art instrumentation to detect even trace levels of impurities, ensuring the material meets the stringent requirements of pharmaceutical synthesis.

Our manufacturing process employs advanced organic synthesis techniques under controlled conditions to ensure reproducibility and safety. We implement Good Manufacturing Practices (GMP) guidelines throughout the production lifecycle, from raw material sourcing to final packaging. This commitment to quality ensures that our clients receive a product that is not only chemically pure but also consistent in its physical properties, facilitating smooth integration into their own synthesis workflows.

Industrial Applications

The primary application of this compound is as a specialized intermediate in the synthesis of Sitagliptin, a widely prescribed dipeptidyl peptidase-4 (DPP-4) inhibitor. The presence of the trifluorophenyl moiety is crucial for the biological activity of the final API. Beyond this specific use, the chemical structure offers versatility for researchers developing novel fluorinated pharmaceutical compounds. The high purity and defined physical characteristics make it suitable for various organic synthesis routes requiring precise stoichiometry and reaction control.

Storage And Handling

To maintain optimal stability, Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate should be stored in a cool, ventilated area away from direct sunlight and moisture. The standard packaging consists of 25 kg drums, which are sealed to prevent contamination and degradation during transit. We also offer custom packaging solutions to meet specific logistical requirements. Proper handling procedures include the use of appropriate personal protective equipment (PPE) to ensure safety during loading and unloading operations. For detailed safety information, please refer to the provided MSDS.

Global Supply And Support

As a global manufacturer, we are committed to providing reliable supply chains for our international partners. We offer competitive bulk pricing structures and flexible logistics options to ensure timely delivery to your facility. Our technical support team is available to assist with application-specific queries and regulatory documentation needs. Contact us today to discuss your requirements for Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate and secure a dependable source for your pharmaceutical production needs.